Biosimilars

Explore the intricate world of biologic medicinal products with "Biosimilars" by Jean-Louis Prugnaud. Published by Springer Editions in 2012, this insightful hardback spans 90 pages and delves into the complexities surrounding biosimilars. Unlike traditional generic drugs, biosimilars face unique challenges due to their inherent heterogeneity and molecular intricacies. In response to these challenges, the European Union has established dedicated regulations to ensure their safe and effective use. This book serves as an essential resource for professionals and students alike, providing a comprehensive understanding of the regulatory landscape and the science behind biosimilars. Enhance your knowledge and stay informed about the evolving field of biologics with this authoritative guide.